DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
ALLHAT Officers and Coordinators for the ALLHAT Collaborative
Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent
Heart Attack Trial.
Major outcomes in high-risk hypertensive patients randomized to
angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
(ALLHAT).
JAMA 2002;
288: 2981-2997
We do not assume any responsibility for the contents of the web pages of other providers.